Latest Breaking News On - Dacima software inc - Page 8 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Colchicine reduces the risk of COVID-19-related complications Montreal Heart InstituteJanuary 23, 2021 GMT MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The analysis of the 4159 patients in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test has shown that the use of colchicine was associated with statistically significant reductions in the risk of death or hospitalization compared to placebo. In these patients with a proven diagnosis of COVID-19, c

South africaUnited statesSophie desmaraisJean claude tardifCamille turbideChristy maginnMontreal heart instituteUs national institutes of healthResearch centerMelinda gates foundationDacima software incPharmascience incMontreal health innovations coordinating centerBlood instituteNational heartPrincipal investigator